Roivant Sciences
Price & Volume
Stats
See more52W Range | $8.73-$23.47 |
Market Cap | $15.2B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $20.3M |
Revenue Growth (YoY) | -64.9% |
Gross Profit (12 Mos) | -$581.7M |
Diluted EPS | -$0.99 |
News
See moreYahoo Finance • 17 days ago
Insider Confidence In December 2025's Leading Growth Companies
Yahoo Finance • last month
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day
Yahoo Finance • 2 months ago
Top Growth Companies With Strong Insider Ownership For November 2025
Yahoo Finance • 2 months ago
Roivant Sciences GAAP EPS of -$0.17 beats by $0.16, revenue of $1.57M misses by $5.35M
About
CEO | Mr. Matthew Gline |
Address | 50 Broadway, London, United Kingdom, SW1H 0DB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 750 |
